ANI Pharmaceuticals, Inc. (ANIP)
Drug Manufacturers - Specialty & Generic · Healthcare · $1.8B
Intrinsic Value (Consensus)
$69.78
Current Price
$79.51
Margin of Safety
-12.2%
12.2% Above Intrinsic Value
Value: $70
Price: $80
Valuation Model Estimates
Current Price: $79.51
DCF (Discounted Cash Flow)
$390.07
Graham Number
$48.18
Earnings Power Value
$58.78
Relative Value (P/E)
$102.38
Dividend Discount Model
Not applicable
—
Consensus Value
$69.78
Model Assumptions
Discount Rate
10.3%
Growth Rate
23.9%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
80
Profitability
18/25
Strength
25/25
Valuation
12/25
Growth
25/25
Financial Health Signals
Low debt — conservative balance sheet
Strong earnings growth (24% YoY)
High free cash flow yield (9.6%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $4.29
- EPS (Forward)
- $5.32
- Book Value
- $24.04
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 14.5%
- Debt/Equity
- 24%
- Revenue Growth
- 43.8%
- Earnings Growth
- 23.9%
- Dividend Yield
- N/A
- Beta
- 0.44
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance